Recall
FDAHealthDecember 12, 2024

Ascend Laboratories, LLC — Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 070

⚠️ CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 12, 2024

Nationwide within the United States

What's affected?

Product
Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60
Lot code
24142328

Additional details

Lot #: 24142328, 24142329, 24142330, Exp. Date May 31, 2026.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1971 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.